OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract LB-208: Hijacking the PI3K/mTor and KRas/MEK/ERK signaling pathways with a therapeutic assault results in robust antitumor activity in PI3K/KRas and KRas mutant tumors

HTML

Year: 2011
Type: conference-abstract
Source: Cancer Research
DOI: 10.1158/1538-7445.am2011-lb-208
Authors: Loic Vincent1, Anne Thomas1, Jianguo Ma2, Anderson Clark2, Jamie Shaw2, Stéphane Guérif1, Coumaran Egile1, Joanne Lager1, Laurent Debussche1, Christoph Lengauer1, Carlos Garcia-Echeverria1, Janet A. Ogden2
Institutions: Sanofi (France), EMD Serono, Inc. (United States)
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PI3K/AKT/mTOR pathway, RAS/MAPK pathway, KRAS mutation, PIK3CA mutation, BRAF mutation, pan-PI3K inhibitor, combination therapy, anticancer activity, colorectal cancer, pancreatic cancer, non-small cell lung cancer, tumor xenografts
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2000648009
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms